Another study by the same group of researchers showed that the in vitro blockage of PD-L1 enhanced IFN-γ production by tumor-infiltrating cells, suggesting that anti-PD-L1 antibodies may have therapeutic effects on cancers in dogs [23]. Here, CD274 is linked to neoplasm.